![]() | Up a level |
Safarnezhad Tameshkel, F. and Karbalaie Niya, M.H. and Zamani, F. and Motamed, N. and Ajdarkosh, H. and Vafaeimanesh, J. and Khoonsari, M. and Sohrabi, M.R. and Aten, S. and Azarkeivan, A. and Eslami, M.S. and Perumal, D. and Maadi, M. and Ghanbari, B. and Keyvani, H. (2020) Resistance-associated substitutions (RASs) to HCV direct-acting antivirals (DAAs) at baseline of treatment in thalassemia patients: a referral center study. Archives of Virology, 165 (10). pp. 2193-2203.